Status Approved
First Submitted Date
2019/11/28
Registered Date
2019/12/06
Last Updated Date
2020/04/27
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0004504 |
---|---|
Unique Protocol ID | KC19EESI0703 |
Public/Brief Title | Optimal timing of transversus abdominis plane block for ambulatory open inguinal herniorrhaphy |
Scientific Title | Comparison of postoperative early recovery between preoperative and postoperative transversus abdominis plane block in male patients undergoing inguinal hernia repair |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | KC19EESI0703 |
Approval Date | 2019-11-19 |
Institutional Review Board Name | Catholic Medical Center Clinical Reseach Coordinating Center |
Institutional Review Board Address | 222, Banpo-daero, Seocho-gu, Seoul |
Institutional Review Board Telephone | 02-2258-8202 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Min Suk Chae |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
Contact Person for Public Queries | |
Name | Jung-Woo Shim |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
Contact Person for Updating Information | |
Name | Jung-Woo Shim |
Title | Dr |
Telephone | +82-2-2258-6150 |
Affiliation | The Catholic University of Korea, Seoul St. Mary's Hospital |
Address | 222 BANPO-DAERO, SEOCHO-GU, SEOUL |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2019-11-20 Actual | |
Target Number of Participant | 80 | |
Primary Completion Date | ||
Study Completion Date | ||
Recruitment Status by Participating Study Site 1 | ||
Name of Study | The Catholic University of Korea, Seoul St. Mary's Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2019-11-20 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | The Catholic University of Korea, Seoul St. Mary's Hospital |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | The Catholic University of Korea, Seoul St. Mary's Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Intravenous opioid has been widely used for postoperative analgeisa after inguinal hernia repair. As the population group undergoing inguinal hernia repair is getting older, side effects such as respiratory depression, urinary retention, constipation, pruritus, nausea or vomitting are increasing. Transverse abdominis plane (TAP) block is proven to be effective for postoperative analgeisa after inguinal hernia repair, decreasing requirements of perioperative opioid use. On the other hand, there have been several studies on the optimal timing of regional block for postoperative analgesia - preoperative block or postoperative block. Thus, the aim of this study is to compare postoperative pain and early recovery between preoperative and postoperative TAP block in male patients undergoing inguinal hernia repair. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Supportive Care |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Subject, Caregiver, Outcome Accessor |
Allocation | RCT |
Intervention Type | Drug |
Intervention Description | For postoperative analgesia, TAP block was performed by experienced anesthesiologists postoperatively in the control group or preoperatively in the experimental group. Under the guidance of ultrasound, 20ml of 0.25% ropivacaine was injected in both groups after confirmation of transversus abdominis plane. |
Number of Arms | 2 |
Arm 1 |
Arm Label postoperative TAP block group |
Target Number of Participant 40 |
|
Arm Type Active comparator |
|
Arm Description General anesthesia was performed using 2mg/kg of intravenous propofol after preoperative TAP block. And general anesthesia was maintained by 4 to 6 vol% of inhaled desflurane via endotracheal tube until the end of the surgery. During the surgery, remifentanil was continuously infused at a rate of 0.05~0.15mcg/kg/min. For postoperative analgesia, TAP block was performed after the operation. Under the guidance of ultrasound, 20ml of 0.25% ropivacaine was injected after confirmation of transversus abdominis plane. |
|
Arm 2 |
Arm Label preoperative TAP block group |
Target Number of Participant 40 |
|
Arm Type Experimental |
|
Arm Description For postoperative analgesia, TAP block was performed preoperatively. Under the guidance of ultrasound, 20ml of 0.25% ropivacaine was injected after confirmation of transversus abdominis plane. General anesthesia was performed using 2mg/kg of intravenous propofol after performing TAP block. And general anesthesia was maintained by 4 to 6 vol% of inhaled desflurane via endotracheal tube until the end of the surgery. During the surgery, remifentanil was continuously infused at a rate of 0.05~0.15mcg/kg/min. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (K00-K93)Diseases of the digestive system (K40.90)Unilateral or unspecified inguinal hernia, without obstruction or gangrene, not specified as recurrent Inguinal hernia |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Male |
Age 19Year~No Limit |
|
Description ASA physical status classification 1 or 2 |
|
Exclusion Criteria |
1. Patients who do not agree to participate in this study 2. Emergency surgery 3. ASA physical status classification 3 or above 4. Preoperative bleeding tendency (INR > 2.0) or taking drugs related to increased bleeding 5. History of allergy to the agents to be administered 6. Intraoperative hemodynamic instability th the extent that colloid infusion/transfusion or vasoactive drugs are necessary |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Not applicable | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Scores in the Korean version of the Quality of Recovery-40 questionnaire |
|
Timepoint | at 24 hours after the operation |
|
Secondary Outcome(s) 1 | ||
Outcome | Peak Visual analogue scale (VAS) pain score |
|
Timepoint | during 24 hours after the operation |
|
Secondary Outcome(s) 2 | ||
Outcome | Rescue pain killer use (time) and VAS pain score (at that time) |
|
Timepoint | during 24 hours after the operation |
|
Secondary Outcome(s) 3 | ||
Outcome | VAS pain score , 1, 6, 24 hours after the operation |
|
Timepoint | at 1, 6, 24 hours after the operation |
|
Secondary Outcome(s) 4 | ||
Outcome | Complications during 24 hours after the operation |
|
Timepoint | during 24 hours after the operation |
|
Secondary Outcome(s) 5 | ||
Outcome | Total hospital stay |
|
Timepoint | At the time of discharge |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동